Demographics Patients RM enrolled (n=332) Group hdRM (n=229) Group odRM (n=103)
p-value
Age, yrs
64.2 ± 17.4
63.8 ± 17.2
65.5 ± 18.0
0.67
Male, n (%)
196 (59.0)
135 (58.9)
61 (59.2)
1
CIED
ICD, n (%)
131 (39.5)
90 (39.3)
41 (39.8)
0.92
Single Chamber, n (%)
56 (16.9)
37 (16.2)
19 (18.4)
0.60
Dual Chamber, n (%)
58 (17.5)
40 (17.4)
18 (17.5)
1
S-ICD, n (%)
17 (5.1)
13 (5.7)
4 (3.9)
0.49
PM, n %
129 (38.8)
89 (38.9)
40 (38.8)
1
Single Chamber, n (%)
20 (6.0)
13 (5.7)
7 (6.8)
0.69
Dual Chamber, n (%)
109 (32.8)
76 (33.2)
33 (32.0)
0.84
ILR, n (%)
53 (16.0)
37 (16.1)
16 (15.6)
0.89
CRT, n (%)
19 (5.7)
13 (5.7)
6 (5.8)
1
Heart Disease
No, n (%)
33 (9.9)
23 (10.0)
10 (9.7)
0.92
Ischaemic HD, n (%)
127 (38.3)
89 (38.9)
38 (36.9)
0.73
Valvular HD, n (%)
36 (10.7)
23 (10.0)
13 (12.6)
0.48
Channelopathies, n (%)
5 (1.5)
3 (1.3)
2 (2.0)
1
Congenital HD, n (%)
2 (0.6)
1 (0.4)
1 (1.0)
1
Others, n (%)
7 (2.1)
5 (2.2)
2 (2.0)
1
NYHA
I, n (%)
90 (27.1)
63 (27.5)
27 (26.2)
0.81
II, n (%)
146 (43.9)
99 (43.2)
47 (45.6)
0.68
III, n (%)
87 (26.2)
60 (26.2)
27 (26.2)
1
IV, n (%)
9 (2.8)
7 (3.1)
2 (2.0)
1
LVEF [range]
45 ± 12 [20 – 60]
44 ± 12 [20 – 60]
47 ± 12 [20 – 60]
0.43
Comorbidities
Diabetes mellitus, n (%)
123 (37.0)
87 (38.0)
36 (35.0)
0.60
Chronic Obstructive Pulmonary Disease, n (%)
54 (16.3)
40 (17.5)
14 (16.5)
0.38
Hypertension, n (%)
174 (52.4)
123 (53.7)
51 (49.5)
0.48
Chronic Kidney Disease, n (%)
67 (20.2)
46 (20.1)
21 (20.4)
1